Skip to Content Facebook Feature Image

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements

Business

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements
Business

Business

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements

2026-03-10 22:13 Last Updated At:22:35

BEIJING, March 10, 2026 /PRNewswire/ -- Beijing Tsingke Biotech Co., Ltd. ("Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at advancing the field of synthetic biology. This collaboration brings together the strengths of both companies to drive innovation, streamline product development, and expand market reach.

Harnessing Expertise to Transform the Industry

Synthetic biology is rapidly emerging as a transformative field with wide-reaching applications, including precision medicine, bio-breeding, and gene editing. At the core of these advancements are high-throughput and column-based synthesis, which Tsingke Biotech and iGeneTech aim to further develop.

Tsingke Biotech, a leader in gene synthesis, has developed a fully integrated industrial chain that spans raw materials, equipment, process design, AI, and digital technologies. Known for its scalability, standardization, and stability, the company's cutting-edge technology includes column synthesis and an intelligent factory-driven production system that supports from small-scale laboratory production (2nmol) to large-scale industrial synthesis (12mmol). Their gene synthesis services include:

  • Primer Synthesis (<300nt)
  • Gene Synthesis (300bp–5kb)
  • Long Gene Synthesis (>5kb)

On the other hand, iGeneTech contributes its proprietary Ignite 3.0 high-throughput synthesis platform. With its ability to process oligo pools ranging from 4k to 650k in size and achieve synthesis lengths up to 200nt with error rates as low as 0.2%, this platform addresses key challenges around throughput, speed, and cost.

A Shared Vision for Growth

"We are excited to partner with iGeneTech, whose expertise in gene capture and next-generation sequencing (NGS) technology enhances our strengths in gene synthesis," said Mr. Shijin Ma, CEO of Tsingke Biotech. "This partnership will speed up the translation of technological innovations into real-world applications, helping drive the industry forward."

Mr. Wanshi Cai, CEO of iGeneTech, added, "Tsingke Biotech's integrated industrial chain and leadership in gene synthesis will be crucial in supporting our continued growth. Together, we will push the boundaries of synthetic biology and its potential across various industries."

Both companies are committed to developing an integrated system that spans the entire spectrum from "synthesis" to "application," focusing on innovation, sustainability, and precision to meet the needs of a rapidly evolving market.

About Tsingke Biotech

Tsingke Biotech is a leading innovator in synthetic biology, with a mission to build "the world's great gene factory." Combining proprietary reagents, consumables, and synthesis equipment with AI-driven molecular manufacturing technologies, Tsingke Biotech provides efficient and high-quality gene synthesis services. Its work supports industries ranging from biopharma to agriculture, food, and environmental sciences.

About iGeneTech

iGeneTech specializes in gene capture technologies and holds intellectual property in NGS probe hybridization, multiplex PCR, and high-throughput DNA synthesis. The company's high-quality oligo pool synthesis capabilities enable the creation of precise and uniform sgRNA libraries for gene-editing applications, including genome-wide and target-gene sgRNA libraries, and off-target detection.

Contact: market@tsingke.com.cn 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements

Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements

Global anniversary campaign marks the first step of the brand's transformation

SINGAPORE, Oct. 5, 2026 /PRNewswire/ -- On the eve of its 63rd anniversary, The Coffee Bean & Tea Leaf® (CBTL) has unveiled a global anniversary campaign, the first milestone in its brand transformation journey. For 63 years, CBTL has brought people together over specialty coffee and tea. Now it's handing the pen to a new generation of artists and creators to write what's next.

At the heart of the refresh are the principles that have guided CBTL from the start: a vision to deliver simply the best coffee and tea experience in every community it serves, and a purpose to help people find their flavor, turning an ordinary day into something a little more special. It builds on what has always set CBTL apart: real craft, made by real people.

That spirit comes to life in a refreshed visual identity that pairs contemporary energy with 63 years of coffee and tea craft. It's bold, expressive and unmistakably CBTL.

Real people are front and center. The campaign features emerging artists, the CBTL brew crew and customers, each with a story to tell across campaign assets, on- and offline. Across participating markets, it will take shape in different ways, reflecting the culture and communities of each place it touches.

"Turning 63 is a moment to look ahead as much as looking back. We've built something lasting on craft and community, and now we're evolving the brand to matter as much to the next generation as it has to the last. This anniversary is the first step of a bigger transformation, and the start of our next chapter of growth." – Ken Lingan, Chief Executive Officer, The Coffee Bean & Tea Leaf®

"We're tuned in to culture and the people driving it, and we're leaning into our role as a creator brand. Craft and self-expression have been part of who we are for 63 years, and this anniversary is as much about celebrating our past as it is about inviting the next generation to bring their own flavor." – Anshul Laroia, Global Head of Marketing, The Coffee Bean & Tea Leaf®

The Story Continues, One Drink at a Time.

The 63rd anniversary campaign marks the first step in CBTL's brand transformation, building on more than six decades of craft, community and heritage. As it unfolds across participating markets, CBTL will continue to invite a new generation to Find Their Flavor.

Keep up with the 63rd Anniversary on cbtl.com/makeityours.

About The Coffee Bean & Tea Leaf®
Headquartered in Asia and a proud member of the Jollibee Group, The Coffee Bean & Tea Leaf® is a modern, global specialty coffee and tea house. With a legacy that began in Southern California in 1963, The Coffee Bean & Tea Leaf® now operates in over 1,200 locations across more than 20 countries. We source the finest coffees and teas from local communities and then handcraft every beverage to bring out the freshest flavors. As the creator of The Original Ice Blended®, we continue to innovate to enable people everywhere to enjoy the classics as well as new flavors, both in our cafés and at home. For more information, visit https://corporate.thecoffeebeanandtealeaf.com.

 

** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **

The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth

The Coffee Bean & Tea Leaf® Turns 63 and Sets a New Direction for Its Next Chapter of Growth

Recommended Articles